VIDEO ACCESS


RELEASE: January 10, 2018
EXPIRATION: December 31, 2019 (Credit is not available after this expiration date.)


LEARNING OBJECTIVES

  • Review the natural history of estrogen receptor (ER) positive breast cancer and define the impact of adjuvant hormonal therapies on the survival of women with early stage ER+ breast cancer
  • Identify critical host and tumor factors that drive resistance to ER targeted therapies
  • Identify new FDA approved therapies and their impact on preventing the progression of metastatic ER positive breast cancer


Accreditation Statement

https://ce.mayo.edu/sites/default/files/CPD-JointAccreditationLogo%20%282%29_0.png

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Credit Statement(s)

AMA

The Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


INSTRUCTIONS

  • Click the Take Course button below.
  • Participate in the quiz. Participants must pass by a minimum of 80%, 1 re-take is allowed. Quizzes have between 2-5 questions.
  • Complete the evaluation.


TRANSCRIPT
This credit will appear on your Transcript for permanent record. To access your transcript, visit My Account, My Activities, RSS Transcript.

DISCLOSURE SUMMARY
As a Jointly Accredited Provider by ACCME, ACPE, and ANCC, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:
Matthew P. Goetz, M.D. 

  • Consultant - Eli Lilly, Genomic Health Innovations
  • Grant/Research Support - Eli Lilly and Pfizer

Aaron Mansfield, M.D.                  Genentech Advisory Board                       Honoraria
John Kisiel, M.D.                           Exact Sciences, Madison, WI                   Intellectual Property
Karna Sundsted                            ACP – MKSAP 18 Writing Committee      Consultant

No relevant financial relationship(s) with industry:

John Bundrick, M.D.
Christina Dilaveri, M.D.
Lucinda Gruber, M.D.
Colin West, M.D., Ph.D.
Amy Williams, M.D.
RaeAnne Boldt

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

QUESTIONS?
MAYO STAFF: Contact RaeAnne Boldt at 3-1846.

MAYO CLINIC CARE NETWORK MEMBERS: Contact cme@mayo.edu 
 

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Presenter: 
Matthew P. Goetz, M.D.
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota